Data Bridge Market Research recently concluded an exhaustive market intelligence study focused on the E-Prescription Market. The freshly released report boasts an engaging layout, effectively presenting crucial data through visually immersive tables, graphs, charts, and figures.

This meticulously crafted E-Prescription market research report systematically collects and evaluates industry data. Its aim is to elucidate vital facts and figures, offering a comprehensive analysis that encompasses market drivers, constraints, segmentation, opportunities, challenges, revenue insights, and competitive assessments. This invaluable resource equips companies with the necessary information to make informed decisions and navigate the intricate landscape of their niche market.

An exceptional team of analysts, experts, statisticians, forecasters, and economists dedicated rigorous efforts to produce this comprehensive and advanced E-Prescription market research report. Serving as a pivotal tool for maintaining a competitive edge, the report explores market segmentation by categorizing potential customers into distinct groups based on product application, deployment models, end-user profiles, and geographical regions.

Moreover, the report provides insights into key players, major collaborations, mergers, acquisitions, and emerging trends in innovation and business strategies within the E-Prescription industry. It consolidates precise and reliable market research data, offering businesses a clear roadmap for informed decision-making and strategic direction.

Data Bridge Market Research predicts significant growth in the e-prescription market, projected to surge from USD 76.31 billion in 2021 to USD 211.65 billion by 2029, with an expected CAGR of 13.60% during the forecast period from 2022 to 2029. Beyond market insights such as value, growth rate, segments, geographical coverage, players, and scenarios, the curated market report by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory frameworks.

 

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-eprescription-market

The need for e-prescriptions across the globe has been made possible by the growing use of technology in many aspects of healthcare. Other growth-promoting technical developments include the creation of products with greater performance capabilities and ease of deployment. These solutions boost patient compliance and organizational workflow by offering affordable generic formulations. Additional factors are projected to fuel the industry, such as the adoption of pro-public health government policies and significant upgrades to the healthcare system. All these factors will propel the market growth during forecast period of 2022 to 2029.

Key Growth Drivers:

  • Increased adoption of EHR solutions

The need for EHR solutions is primarily driven by the government's expanding support for the adoption of EHR solutions and the need to control the rapidly rising healthcare costs. The implementation of electronic health records has simplified prescription filling in several ways. The integrating solutions offer a better availability of medical histories than a standalone e-prescribing system. The global COVID-19 outbreak has also increased the number of patients in hospitals, necessitating improved patient data management. This is anticipated to increase demand for these solutions.

  • Increasing E-prescription in hospitals

Doctors are finding themselves better equipped with technology replacing something basic but crucial in healthcare as prescribing medicine becomes easier. A computer created, communicated, and filed out medical prescription is known as a "e-prescription." Its primary goal is to reduce the need of paper prescriptions and the danger of prescription error. These are the factors which propel the growth of the market.

The report outlines the involvement of key players, including:

Epic Systems Corporation (U.S.), Cerner Corporation (U.S.), Allscripts Healthcare, LLC. (U.S.), NXGN Management, LLC. (U.S.), athenahealth, Inc. (U.S.), RelayHealth, LLC (U.S.), Henry Schein, Inc. (U.S.), General Electric (U.S.), CPSI (U.S.), DrFirst (U.S.) and Medical Information Technology, Inc. (U.S.)

Key Market Segmentation

Product (Solutions, Services), Usage Mode (Handheld Device, Computer-Based Devices), Mode of Delivery (Web and Cloud-Based Solutions, On-Premise Solutions), End-User (Clinics, Physicians, Pharmacies, Hospitals) 

North America dominates the e-prescription market owing to high number of government initiatives and incentives in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and increasing demand for advanced medical technology.

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-eprescription-market

 

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-mycophenolate-market

https://www.databridgemarketresearch.com/reports/global-variant-creutzfeldt-jakob-disease-treatment-market

https://www.databridgemarketresearch.com/reports/global-anti-money-laundering-market

https://www.databridgemarketresearch.com/reports/europe-anti-money-laundering-market

https://www.databridgemarketresearch.com/reports/asia-pacific-anti-money-laundering-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com